Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2019.593 | A Retrospective Study of Computer-assisted Cognitive Training Program (CCTP) for psychiatric patients with Severe Mental Illness (SMI) |
Ms. LAU Ching Man 劉靖雯 |
| 2019.605 | Continuous glucose monitoring as an adjunct to lifestyle modification in individuals with impaired glucose tolerance: a randomised controlled trial |
Dr. CHOW Elaine Yee Kwan 周怡君 |
| 2019.594 | Early Prediction of Fragility Fracture Risk using 3D High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) in Hong Kong Community |
Prof. CHEUNG Wing Hoi 張穎愷 |
| 2019.608 | Effects of Acceptance and Commitment Therapy-based asthma management training program for parents of young children with neurodevelopmental comorbidities: A randomized controlled trial |
Dr. CHONG Yuen Yu 莊婉瑜 |
| 2019.619 | The First Congenital Upper Limb Anomalies (CULA) Database in Hong Kong: Registry of CULA in Prince of Wales Hospital | Prof. CHEUNG Wing Hoi |
| 2019.604 | Translation and Validation of the Traditional Chinese Version of Food Allergy Quality of Life Questionnaire Series |
Prof. LEUNG Ting Fan 梁廷勳 |
| 2019.621 | Potential cost-effectiveness of mobile health and internet technology-supported mental health interventions for university students – A health economic analysis |
Prof. YOU Joyce Hoi Sze 姚凱詩 |
| 2019.616 | Economic evaluation on breastfeeding promotion in Hong Kong |
Dr. HUI Lai Ling 許麗玲 |
| 2019.607 | A novel augmented reality system (ARssist) for the assistant surgeon in robotic assisted surgery: A pilot study |
Prof. TEOH Jeremy Yuen Chun 張源津 |
| 2019.610 | Community eHealth Care Project | Prof. WONG Samuel |
| 2019.614 | An integrated omics study of the gut microbiome in infantile food allergy |
Dr. LEUNG Agnes Sze Yin 梁詩彥 |
| 2019.628 | Prevalence of obstructive sleep apnea (OSA) and the association with cognitive impairment | Dr. CHAN Ka Pang |
| 2019.613 | A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer (CheckMate 7DX: CHECKpoint pathway and nivoluMAB clinical Trial Evaluation 7DX) |
Dr. POON Darren Ming Chun 潘明駿 |
| 2019.609 | A PHASE 1/2 DOSE ESCALATION AND DOSE EXPANSION STUDY OF OZURIFTAMAB VEDOTIN (BA3021) ALONE AND IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS | Dr. LOONG Herbert H.F. |
| 2019.622 | Dosimetric Effects of Collimator Angles in Volumetric Modulated Arc Therapy Planning in Cancers of the Left Breast |
Mr. YU Kai Shing 余啟成 |
| 2019.591 | Preliminary study on the effectiveness of self-management educational program on patients with osteoporotic vertebral fracture suffering from chronic back pain |
Ms. HUI Sin Ting 許倩婷 |
| 2019.617 | Evaluation of SQLE as a novel therapeutic target in non-alcoholic fatty liver disease |
Prof. YU Jun 于君 |
| 2019.588 | Can regular participation in physical exercise improve retinal microvasculature in community-dwelling Chinese adults with subjective cognitive decline? A randomized controlled trial. | Dr. LEE Allen Ting Chun |
| 2019.611 | Molecular stratification of adult gliomas for prognostication using next generation sequencing approach | Prof. NG Ho Keung |
| 2019.582 | Autologous Umbilical Cord Blood Mononuclear Cells for Treatment of Neonatal and Infant Complications |
Dr. WANG Chi Chiu 黄志超 |
| 2019.584 | A randomized, open-label, multicenter phase II study evaluating the efficacy and safety of capmatinib (INC280) plus pembrolizumab versus pembrolizumab alone as first line treatment for locally advanced or metastatic non-small cell lung cancer with PD-L1≥ 50% |
Prof. MOK Tony Shu Kam 莫樹錦教授 |
| 2019.620 | Incidence and risk factors for development of implant failure after spinal instrumentation for spinal metastasis | Dr. WONG Yu Chung |
| 2019.585 | A Phase III, Randomised, Double-Blind, Placebo-Controlled, Multicentre Study of Durvalumab as Consolidation Therapy in Patients with Locally Advanced, Unresectable, Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed following Definitive, Platinum-Based, Chemoradiation Therapy (PACIFIC 5) |
Dr. LOONG Herbert H.F. 龍浩鋒醫生 |
| 2019.589 | Embodying a compassionate self through Acceptance and Commitment Therapy for parents and children with eczema: A family based eczema management programme |
Dr. CHONG Yuen Yu 莊婉瑜 |
| 2019.587 | Estrogen receptor alpha down-regulates sodium iodide symporter (NIS) via stimulating forkhead box P3 (FOXP3) in papillary thyroid cancer |
Prof. TONG Michael Chi Fai 唐志輝 |
| 2019.580 | Blood pressure control with thiazide diuretics in peritoneal dialysis patients with residual renal function | Dr. CHOW Kai Ming |
| 2019.581 | Epidemiology and determinants of outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care (EUROBACT II) | Dr. LING Lowell |
| 2019.631 | The effectiveness of pharmacist-led medication reconcilliation service on the care of renal patients in orthopedic wards of Alice Ho Miu Ling Nethersole Hospital | Mr. CHEUNG Jun Kin |
| 2019.618 | Opioid analgesics during and following radiotherapy treatment of head and neck tumours | Dr. CHAN Jason Ying Kuen |
| 2019.627 | The effect of technology-based cognitive training in patients with post-stroke cognitive impairment in Geriatric Day Hospital and Rehabilitation Center: A retrospective study |
Ms. FAN Silvia Hiu Ue 樊曉榆 |
| 2019.563 | Model establishment for metastasis prediction and identification of preventive herbal medicine in colorectal cancer using patient-derived xenografts |
Dr. YUE Grace Gar Lee 余嘉莉 |
| 2019.550 | CATALYST 207: A PHASE 2, PILOT, EXPLORATORY STUDY EVALUATING THE SAFETY AND ANTIVIRAL EFFICACY OF INARIGIVIR SOPROXIL IN NON-CIRRHOTIC TREATMENT-NAÏVE SUBJECTS INFECTED WITH CHRONIC HEPATITIS B VIRUS |
Dr. HUI Aric Josun 許祖紳醫生 |
| 2019.557 | Malnutrition risk, nutrition intakes and clinical outcomes of Chronic Obstructive Pulmonary Disease (COPD) inpatients |
Dr. TING Terry Ho Yan 丁浩恩 |
| 2019.578 | Recreational noise exposure and its effects on the hearing in young adults | Mr. CHAN Parky |
| 2019.538 | The therapeutic effect of a combined therapy of Tui-na and oral Chinese medicine on Osteoarthritis of Knee - A randomized wait-list controlled trial |
Prof. LIN Zhixiu 林志秀 |
| 2019.556 | A multiple health risk assessment using automatic retinal image analysis (ARIA) for the community. |
Prof. ZEE Benny Chung Ying 徐仲鍈 |
| 2019.553 | AXEL: Axitinib-Avelumab combination in recurrent or metastatic nasopharyngeal cancer: a multicenter phase 2 trial |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2019.551 | A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF INAVOLISIB PLUS PALBOCICLIB AND FULVESTRANT VERSUS PLACEBO PLUS PALBOCICLIB AND FULVESTRANT IN PATIENTS WITH PIK3CA-MUTANT, HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER |
Prof. YEO Winnie 楊明明 教授 |
| 2019.547 | Safety and Effectiveness IDE trial for Boston Scientific’s Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation (FROzEN-AF) |
Dr. CHAN Joseph Yat Sun 陳日新醫生 |
| 2019.541 | A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients with Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1) |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2019.540 | A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). |
Dr. TAM Lai Shan 譚麗珊 |
| 2019.576 | Mother-to-Infant Transfer of Bacteriome, Fungome, Virome, and Metabolome in Health and Crohn's disease (MoMmy-CD) |
Prof. NG Siew Chien 黃秀娟 |
| 2019.558 | DeFect cLOsure After colonic ESD with underwaTer technique versus conventional clip : a randomized controlled trial (FLOAT trial) |
Dr. YIP Hon Chi 葉瀚智 |
| 2019.561 | Endoscopic closure of mucosal defect after high-risk gastric endoscopic submucosal dissection (ESD) - a pilot study |
Dr. YIP Hon Chi 葉瀚智 |
| 2019.577 | Outcome of Prophylactic Precaesarean Iliac Artery Balloon Insertion in Patients with Abnormal Placental Implantation. |
Dr. TSAI Siu Chun 蔡紹俊 |
| 2019.555 | A Phase Ia/Ib, Open-Label, Dose-Escalation and Dose-Expansion Study of the Anti-CTLA-4 Monoclonal Antibody CS1002 as Monotherapy and in Combination with Anti-PD-1 Monoclonal Antibody CS1003 in Subjects with Advanced Solid Tumors |
Dr. CHAN Stephen Lam 陳林 |
| 2019.554 | A Phase 1, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 in Subjects of Chinese Descent With Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation (CodeBreaK 105) |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2019.579 | Comparative Persistence With Prolia® and Weekly Alendronate in 6 Asia-Pacific countries: a Prospective Observational Study |
Dr. WONG Ronald Man Yeung 黃文揚 |
| 2019.567 | Early Intelligent Diagnosis and Advanced Intervention for Stroke Neurorehabilitation |
Prof. TONG Kai Yu 湯啟宇 |
| 2019.568 | Centre for Novostics |
Prof. LO Dennis Yuk Ming 盧 煜 明 |
Page 65 of 254.